Gene Bio Tech

086060 · KOSDAQ · ₩086060 · 진바이오텍

₩5,140▲ ₩60 (1.18%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me

Income statement

20252024202320222021
Revenue₩91B₩83B₩79B₩83B₩63B
Cost of sales₩76B₩69B₩66B₩72B₩55B
Gross profit₩14B₩14B₩14B₩10B₩7.6B
Operating income₩3.9B₩3.8B₩4B₩1.7B−₩208M
Net income₩3.8B₩2.9B₩2.6B₩1.5B−₩484M
Net income to shareholders₩3.8B₩2.9B₩2.6B₩1.5B−₩493M

Balance sheet

20252024202320222021
Total assets₩76B₩72B₩66B₩64B₩60B
Current assets₩55B₩56B₩49B₩46B₩42B
Cash and equivalents₩9.6B₩10B₩8.8B₩7.4B₩7.4B
Total liabilities₩21B₩21B₩18B₩18B₩16B
Current liabilities₩16B₩18B₩15B₩16B₩14B
Borrowings₩15B₩16B₩12B₩13B₩10B
Total equity₩55B₩51B₩48B₩46B₩44B
Shareholders' equity₩55B₩51B₩48B₩46B₩44B

Cash flow

20252024202320222021
Cash from operations₩7.6B−₩464M₩7.4B−₩3.7B−₩2.8B
Capital spending₩3.8B₩1.1B₩530M₩1.2B₩3.1B
Free cash flow₩3.9B−₩1.6B₩6.8B−₩4.8B−₩5.9B
Dividends paid——₩0—₩258M

Consolidated where available. Amounts in won.

Also known as: Gene Bio Tech / 진바이오텍 / 086060 / KRX:086060

Source: KRX statistical information